It has been frequently shown that nanoparticles are able to increase the efficiency of
antitumor drugs, decrease their side effects, and control distribution profile of drug
molecules. In addition, these particular systems can enhance pharmacokinetics and
pharmacodynamics properties of drugs through a physical pathway. This novel strategy can
prevent drugs entering systemic circulation, and can confine the access of drugs to a specific
target. Various polymeric nanoparticles have been used for the encapsulation of anticancer …